Jennifer Correa Email

Director Regulatory Affairs . JenaValve Technology

Current Roles

Employees:
182
Revenue:
$57.1M
About
JenaValve Technology, Inc., with locations in Irvine, Calif., Leeds, U.K. and Munich, Germany, develops and manufactures transcatheter aortic valve replacement (TAVR) systems to treat patients suffering from aortic valve disease. The Company is in clinical development of its next-generation transfemoral TAVR system in both the U.S. and CE mark countries for treating patients with aortic stenosis and/or aortic regurgitation. In addition to Bain Capital Life Sciences, JenaValve is backed by European and Asian investors, including Andera Partners (formerly Edmond de Rothschild Investment Partners), Gimv (Euronext: GIMB), Legend Capital, NeoMed Management, RMM, Valiance Life Sciences and VI Partners. Additional information is available at www.jenavalve.com.
JenaValve Technology Address
4 cromwell
Irvine, CA
United States
JenaValve Technology Email

Past Companies

JenaValve Technology, Inc.Director of Regulatory Affairs
MedtronicRegulatory Affairs Program Manager
MedtronicRegulatory Affairs Manager

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.